301060 兰卫医学
已收盘 02-05 15:00:00
资讯
新帖
简况
股市必读:兰卫医学(301060)1月30日董秘有最新回复
证券之星 · 02-02
股市必读:兰卫医学(301060)1月30日董秘有最新回复
兰卫医学:公司建设了数字切片标准集项目
证券之星 · 01-30
兰卫医学:公司建设了数字切片标准集项目
股市必读:兰卫医学(301060)1月29日董秘有最新回复
证券之星 · 01-30
股市必读:兰卫医学(301060)1月29日董秘有最新回复
兰卫医学:预计2025年全年归属净利润亏损2000万元至3800万元
证券之星 · 01-28
兰卫医学:预计2025年全年归属净利润亏损2000万元至3800万元
兰卫医学(301060)披露董事会秘书辞职暨聘任新任董事会秘书,1月16日股价下跌3.95%
证券之星 · 01-16
兰卫医学(301060)披露董事会秘书辞职暨聘任新任董事会秘书,1月16日股价下跌3.95%
千亿出海+天价猴!CRO板块扎堆涨停,这波红利能吃到2026?
中金财经 · 01-13
千亿出海+天价猴!CRO板块扎堆涨停,这波红利能吃到2026?
异动快报:兰卫医学(301060)1月13日9点55分触及涨停板
证券之星 · 01-13
异动快报:兰卫医学(301060)1月13日9点55分触及涨停板
兰卫医学:项目已通过相关单位验收
证券之星 · 2025-12-30
兰卫医学:项目已通过相关单位验收
兰卫医学:未触及退市相关情形
证券之星 · 2025-12-05
兰卫医学:未触及退市相关情形
兰卫医学:截至2025年9月30日股东人数21,745名
证券之星 · 2025-11-27
兰卫医学:截至2025年9月30日股东人数21,745名
股市必读:兰卫医学(301060)11月11日董秘有最新回复
证券之星 · 2025-11-12
股市必读:兰卫医学(301060)11月11日董秘有最新回复
兰卫医学:截至2025年9月30日股东人数为21,745名
证券之星 · 2025-11-11
兰卫医学:截至2025年9月30日股东人数为21,745名
兰卫医学(301060)2025年三季报简析:亏损收窄,盈利能力上升
证券之星 · 2025-10-29
兰卫医学(301060)2025年三季报简析:亏损收窄,盈利能力上升
图解兰卫医学三季报:第三季度单季净利润同比增长109.11%
证券之星 · 2025-10-28
图解兰卫医学三季报:第三季度单季净利润同比增长109.11%
兰卫医学连亏两年半 2021年上市募资2亿国金证券保荐
中金财经 · 2025-09-24
兰卫医学连亏两年半 2021年上市募资2亿国金证券保荐
兰卫医学:截至2025年6月30日普通股股东总数为23,197
证券之星 · 2025-09-22
兰卫医学:截至2025年6月30日普通股股东总数为23,197
兰卫医学(301060)2025年中报简析:净利润同比下降137.08%,公司应收账款体量较大
证券之星 · 2025-08-27
兰卫医学(301060)2025年中报简析:净利润同比下降137.08%,公司应收账款体量较大
图解兰卫医学中报:第二季度单季净利润同比下降84.18%
证券之星 · 2025-08-26
图解兰卫医学中报:第二季度单季净利润同比下降84.18%
兰卫医学(301060)2月19日主力资金净买入2452.04万元
证券之星 · 2025-02-20
兰卫医学(301060)2月19日主力资金净买入2452.04万元
兰卫医学(301060)2月18日主力资金净卖出3346.39万元
证券之星 · 2025-02-19
兰卫医学(301060)2月18日主力资金净卖出3346.39万元
加载更多
公司概况
公司名称:
上海兰卫医学检验所股份有限公司
所属行业:
卫生
上市日期:
2021-09-13
主营业务:
上海兰卫医学检验所股份有限公司的主营业务是向各级医疗机构提供第三方医学检验和病理诊断服务、国内外知名品牌体外诊断产品以及其他专业技术支持。公司的主要产品是体外诊断产品、医学诊断服务。
发行价格:
4.17
{"stockData":{"symbol":"301060","market":"SZ","secType":"STK","nameCN":"兰卫医学","latestPrice":11.26,"timestamp":1770275037000,"preClose":11.33,"halted":0,"volume":5143355,"delay":0,"changeRate":-0.0062,"floatShares":360000000,"shares":401000000,"eps":-0.1736,"marketStatus":"已收盘","change":-0.07,"latestTime":"02-05 15:00:00","open":11.29,"high":11.46,"low":11.22,"amount":58271500,"amplitude":0.0212,"askPrice":11.26,"askSize":162,"bidPrice":11.25,"bidSize":42,"shortable":0,"etf":0,"ttmEps":-0.1736,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770341400000},"marketStatusCode":5,"adr":0,"adjPreClose":11.33,"symbolType":"stock","openAndCloseTimeList":[[1770255000000,1770262200000],[1770267600000,1770274800000]],"highLimit":12.46,"lowLimit":10.2,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":400517000,"isCdr":false,"pbRate":2.88,"roa":"--","roe":"--","epsLYR":-0.27,"committee":0.164333,"marketValue":4510000000,"turnoverRate":0.0143,"status":1,"floatMarketCap":4056000000},"requestUrl":"/m/hq/s/301060","defaultTab":"news","newsList":[{"id":"2608886888","title":"股市必读:兰卫医学(301060)1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608886888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608886888?lang=zh_cn&edition=full","pubTime":"2026-02-02 01:55","pubTimestamp":1769968512,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,兰卫医学报收于11.23元,下跌1.49%,换手率3.52%,成交量12.68万手,成交额1.42亿元。董秘最新回复投资者: 请问公司是否有使用AI智能体等相关技术和产品?公司建设了数字切片标准集项目,该项目已获得上海市经信委终验通过,具体情况烦请持续关注公司相关公告。交易信息汇总资金流向1月30日主力资金净流出2367.41万元;游资资金净流出1563.14万元;散户资金净流入3930.55万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200000894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301060"],"gpt_icon":0},{"id":"2607064017","title":"兰卫医学:公司建设了数字切片标准集项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2607064017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607064017?lang=zh_cn&edition=full","pubTime":"2026-01-30 11:33","pubTimestamp":1769744022,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学(301060)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司是否有使用AI智能体等相关技术和产品?谢谢兰卫医学回复:尊敬的投资人您好,感谢您对公司的关注与支持!公司建设了数字切片标准集项目,该项目已获得上海市经信委终验通过,具体情况烦请持续关注公司相关公告。 谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000016609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301060"],"gpt_icon":0},{"id":"2607535860","title":"股市必读:兰卫医学(301060)1月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2607535860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607535860?lang=zh_cn&edition=full","pubTime":"2026-01-30 03:26","pubTimestamp":1769714774,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘,兰卫医学报收于11.4元,下跌0.52%,换手率3.59%,成交量12.92万手,成交额1.48亿元。如需了解公司开展的具体检测项目,请您登录兰卫医学官方网站查询。交易信息汇总资金流向1月29日主力资金净流出201.19万元;游资资金净流出588.26万元;散户资金净流入789.45万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000003116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0},{"id":"2606979715","title":"兰卫医学:预计2025年全年归属净利润亏损2000万元至3800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606979715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606979715?lang=zh_cn&edition=full","pubTime":"2026-01-28 20:03","pubTimestamp":1769601810,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学发布业绩预告,预计2025年全年归属净利润亏损2000万元至3800万元。公告中解释本次业绩变动的原因为:1、报告期内,公司主动适配国家政策及行业发展趋势,推进业务结构优化与大区一体化运营升级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800038656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060"],"gpt_icon":0},{"id":"2603991127","title":"兰卫医学(301060)披露董事会秘书辞职暨聘任新任董事会秘书,1月16日股价下跌3.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991127","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603991127?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:11","pubTimestamp":1768572676,"startTime":"0","endTime":"0","summary":"公司于近日发布公告称,上海兰卫医学检验所股份有限公司董事会于近日收到董事会秘书高文俊先生的书面辞职报告,其因个人原因辞去董事会秘书职务,辞职后仍担任公司顾问。公司于2026年1月16日召开第四届董事会第八次会议,聘任杨晶晶女士为新任董事会秘书,任期至第四届董事会届满。杨晶晶女士已取得董事会秘书资格证书和法律职业资格证书,具备履职能力,目前兼任证券事务代表。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600040873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0},{"id":"2603750260","title":"千亿出海+天价猴!CRO板块扎堆涨停,这波红利能吃到2026?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603750260","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603750260?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:30","pubTimestamp":1768296601,"startTime":"0","endTime":"0","summary":"据悉,2025年国内创新药BD出海金额突破1000亿美元,2026年预期加速,CRO企业作为研发外包核心服务商直接受益于订单放量。另外,2025年12月,广东、广西等地猴场实验猴已订至2026年上半年,供不应求局面持续,推动CRO企业战略资源溢价。一猴难求除了创新药出海带来的订单红利,实验猴资源的稀缺性进一步推升了CRO企业的战略价值。机构看好企业发展前景机构普遍看好CRO板块2026年的发展前景。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260113/31938136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301230","BK0197","BK0028","BK0070","301060","BK0216","301333","06978","688137","BK0186","301257","BK1574","300244","BK1161","BK0236","BK0114","BK0146","BK0042","300404"],"gpt_icon":0},{"id":"2603737755","title":"异动快报:兰卫医学(301060)1月13日9点55分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603737755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603737755?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:01","pubTimestamp":1768269661,"startTime":"0","endTime":"0","summary":"证券之星1月13日盘中消息,9点55分兰卫医学触及涨停板。其所属行业医疗服务目前上涨。领涨股为泓博医药。该股为AI医疗,基因测序,猴痘概念概念热股,当日AI医疗概念上涨2.95%,基因测序概念上涨2.91%,猴痘概念概念上涨2.04%。1月12日的资金流向数据方面,主力资金净流入189.67万元,占总成交额0.97%,游资资金净流出928.29万元,占总成交额4.75%,散户资金净流入738.62万元,占总成交额3.78%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300010225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301060"],"gpt_icon":0},{"id":"2595768026","title":"兰卫医学:项目已通过相关单位验收","url":"https://stock-news.laohu8.com/highlight/detail?id=2595768026","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595768026?lang=zh_cn&edition=full","pubTime":"2025-12-30 11:33","pubTimestamp":1767065634,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学(301060)12月29日在投资者关系平台上答复投资者关心的问题。投资者提问:人工智能、云计算、大数据等新兴技术对医疗行业特别是医疗诊断领域的促进和引领,贵公司“基于病理数字切片标注的单病种智能初筛机器人诊断标准数据集前期提交的审核是否通过?兰卫医学回复:尊敬的投资人您好,感谢您对公司的关注与支持!目前该项目已通过相关单位的验收,后续情况烦请持续关注公司相关公告。 谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000016075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301060"],"gpt_icon":0},{"id":"2589975258","title":"兰卫医学:未触及退市相关情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2589975258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589975258?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:51","pubTimestamp":1764939089,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学(301060)12月04日在投资者关系平台上答复投资者关心的问题。投资者提问:有退市风险吗?兰卫医学回复:尊敬的投资人您好,感谢您对公司的关注与支持!公司目前生产经营情况一切正常,根据《深圳证券交易所创业板股票上市规则》的相关规定,公司未触及退市相关情形。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500036960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0},{"id":"2586774245","title":"兰卫医学:截至2025年9月30日股东人数21,745名","url":"https://stock-news.laohu8.com/highlight/detail?id=2586774245","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586774245?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:30","pubTimestamp":1764235835,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学(301060)11月27日在投资者关系平台上答复投资者关心的问题。投资者提问:请问10月31日的股东人数是多少,谢谢兰卫医学回复:尊敬的投资人您好,感谢您对公司的关注与支持!公司已于2025年三季度报告中披露定期时点的股东数量:截至2025年9月30日,公司股东人数共计21,745名。如需查询其他时点的股东人数,烦请提供有效持股证明和身份证扫描件等材料发送至公司公开披露的邮箱,公司审核后予以提供。 谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700025487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0},{"id":"2582108394","title":"股市必读:兰卫医学(301060)11月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582108394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582108394?lang=zh_cn&edition=full","pubTime":"2025-11-12 03:45","pubTimestamp":1762890315,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘,兰卫医学报收于10.12元,上涨0.8%,换手率1.43%,成交量5.17万手,成交额5210.46万元。董秘最新回复投资者: 请问截至2025年11月10日,公司股东人数是多少?公司已于2025年三季度报告中披露定期时点的股东数量:截至2025年9月30日,公司股东人数共计21,745名。当日关注点来自交易信息汇总:11月11日主力资金净流出365.33万元,散户资金净流入289.0万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200002879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301060"],"gpt_icon":0},{"id":"2582357293","title":"兰卫医学:截至2025年9月30日股东人数为21,745名","url":"https://stock-news.laohu8.com/highlight/detail?id=2582357293","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582357293?lang=zh_cn&edition=full","pubTime":"2025-11-11 11:33","pubTimestamp":1762832029,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学(301060)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2025年11月10日,公司股东人数是多少?兰卫医学回复:尊敬的投资人您好,感谢您对公司的关注与支持!公司已于2025年三季度报告中披露定期时点的股东数量:截至2025年9月30日,公司股东人数共计21,745名。如需查询其他时点的股东人数,烦请提供有效持股证明和身份证扫描件等材料发送至公司公开披露的邮箱,公司审核后予以提供。 谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100014167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0},{"id":"2579491699","title":"兰卫医学(301060)2025年三季报简析:亏损收窄,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579491699","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579491699?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:43","pubTimestamp":1761691423,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期兰卫医学发布2025年三季报。截至本报告期末,公司营业总收入11.02亿元,同比下降16.51%,归母净利润-66.77万元,同比上升98.35%。按单季度数据看,第三季度营业总收入3.43亿元,同比下降20.63%,第三季度归母净利润511.54万元,同比上升109.11%。本报告期兰卫医学盈利能力上升,毛利率同比增幅15.2%,净利率同比增幅122.99%。本次财报公布的各项数据指标表现一般。),公司上市来已有年报3份,亏损年份2次,显示生意模式比较脆弱。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900010885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301060"],"gpt_icon":0},{"id":"2578622547","title":"图解兰卫医学三季报:第三季度单季净利润同比增长109.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578622547","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578622547?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:21","pubTimestamp":1761589269,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学2025年三季报显示,公司主营收入11.02亿元,同比下降16.51%;归母净利润-66.77万元,同比上升98.35%;扣非净利润-753.75万元,同比上升84.79%;其中2025年第三季度,公司单季度主营收入3.43亿元,同比下降20.63%;单季度归母净利润511.54万元,同比上升109.11%;单季度扣非净利润10.57万元,同比上升100.17%;负债率31.28%,投资收益-76.79万元,财务费用219.35万元,毛利率24.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800001969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060"],"gpt_icon":0},{"id":"2569726411","title":"兰卫医学连亏两年半 2021年上市募资2亿国金证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2569726411","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569726411?lang=zh_cn&edition=full","pubTime":"2025-09-24 10:46","pubTimestamp":1758681976,"startTime":"0","endTime":"0","summary":"中国经济网北京9月24日讯 兰卫医学 日前发布2025年半年度报告。今年上半年,公司实现营业收入7.59亿元,同比减少14.50%;归属于上市公司股东的净利润-578.32万元,同比减少137.08%;归属于上市公司股东的扣除非经常性损益的净利润-764.32万元,同比减少170.04%;经营活动产生的现金流量净额3723.41万元,上年同期为-4813.76万元。 兰卫医学上市发行费用总额为6139.68万元,其中保荐机构国金证券股份有限公司获得承销及保荐费用4187.00万元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202509/24/20250924261083.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202509/24/20250924261083.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20250924/31668957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","BK0028","BK0201","BK0012","BK0188","BK0183","301060","600109","BK0236"],"gpt_icon":0},{"id":"2569760202","title":"兰卫医学:截至2025年6月30日普通股股东总数为23,197","url":"https://stock-news.laohu8.com/highlight/detail?id=2569760202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569760202?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:31","pubTimestamp":1758529879,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学(301060)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的领导,你好,请问兰卫医学这家上市公司最近持有的股东户数是多少?兰卫医学回复:尊敬的投资人您好,感谢您对公司的关注与支持!公司截至2025年6月30日普通股股东总数 为23,197 ,如需查询其他时点的股东人数,烦请提供有效持股证明和身份证扫描件等材料发送至公司公开披露的邮箱,公司审核后予以提供。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200021031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0},{"id":"2562763758","title":"兰卫医学(301060)2025年中报简析:净利润同比下降137.08%,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2562763758","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562763758?lang=zh_cn&edition=full","pubTime":"2025-08-27 06:34","pubTimestamp":1756247680,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期兰卫医学发布2025年中报。截至本报告期末,公司营业总收入7.59亿元,同比下降14.5%,归母净利润-578.32万元,同比下降137.08%。本报告期兰卫医学公司应收账款体量较大,当期应收账款占最新年报营业总收入比达46.88%。短期借款变动幅度为-36.89%,原因:报告期归还银行贷款。其他应付款变动幅度为251.36%,原因:报告期子公司分红款尚未支付。投资活动产生的现金流量净额变动幅度为53.86%,原因:报告期购置长期资产较同期减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700009738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060"],"gpt_icon":0},{"id":"2562221899","title":"图解兰卫医学中报:第二季度单季净利润同比下降84.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562221899","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562221899?lang=zh_cn&edition=full","pubTime":"2025-08-26 01:36","pubTimestamp":1756143403,"startTime":"0","endTime":"0","summary":"证券之星消息,兰卫医学2025年中报显示,公司主营收入7.59亿元,同比下降14.5%;归母净利润-578.32万元,同比下降137.08%;扣非净利润-764.32万元,同比下降170.04%;其中2025年第二季度,公司单季度主营收入4.09亿元,同比下降9.58%;单季度归母净利润229.77万元,同比下降84.18%;单季度扣非净利润323.08万元,同比下降68.53%;负债率33.89%,投资收益-182.2万元,财务费用213.91万元,毛利率22.55%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600003340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060"],"gpt_icon":0},{"id":"2512576114","title":"兰卫医学(301060)2月19日主力资金净买入2452.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512576114","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512576114?lang=zh_cn&edition=full","pubTime":"2025-02-20 09:19","pubTimestamp":1740014359,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年2月19日收盘,兰卫医学报收于11.68元,上涨5.23%,换手率6.27%,成交量22.37万手,成交额2.54亿元。近5日资金流向一览见下表:兰卫医学融资融券信息显示,融资方面,当日融资买入2136.43万元,融资偿还1526.96万元,融资净买入609.48万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022000007868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0},{"id":"2512110874","title":"兰卫医学(301060)2月18日主力资金净卖出3346.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512110874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512110874?lang=zh_cn&edition=full","pubTime":"2025-02-19 09:19","pubTimestamp":1739927958,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年2月18日收盘,兰卫医学报收于11.1元,下跌6.41%,换手率6.68%,成交量23.81万手,成交额2.71亿元。近5日资金流向一览见下表:兰卫医学融资融券信息显示,融资方面,当日融资买入1370.9万元,融资偿还2102.22万元,融资净偿还731.32万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900008930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301060","BK0236"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770313495621,"stockEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0964},{"period":"3month","weight":0.1374},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2483},{"period":"ytd","weight":0.2173}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":-0.0019},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.2621},{"period":"ytd","weight":0.027}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海兰卫医学检验所股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"21745人(较上一季度减少6.26%)","perCapita":"16564股","listingDate":"2021-09-13","address":"上海市长宁区临新路268弄1号楼4-9层","registeredCapital":"40051万元","survey":" 上海兰卫医学检验所股份有限公司的主营业务是向各级医疗机构提供第三方医学检验和病理诊断服务、国内外知名品牌体外诊断产品以及其他专业技术支持。公司的主要产品是体外诊断产品、医学诊断服务。","listedPrice":4.17},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兰卫医学(301060)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兰卫医学(301060)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兰卫医学,301060,兰卫医学股票,兰卫医学股票老虎,兰卫医学股票老虎国际,兰卫医学行情,兰卫医学股票行情,兰卫医学股价,兰卫医学股市,兰卫医学股票价格,兰卫医学股票交易,兰卫医学股票购买,兰卫医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兰卫医学(301060)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兰卫医学(301060)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}